These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14755287)

  • 1. Phage-inspired antibiotics?
    Projan S
    Nat Biotechnol; 2004 Feb; 22(2):167-8. PubMed ID: 14755287
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial drug discovery through bacteriophage genomics.
    Liu J; Dehbi M; Moeck G; Arhin F; Bauda P; Bergeron D; Callejo M; Ferretti V; Ha N; Kwan T; McCarty J; Srikumar R; Williams D; Wu JJ; Gros P; Pelletier J; DuBow M
    Nat Biotechnol; 2004 Feb; 22(2):185-91. PubMed ID: 14716317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural protein analysis of the polyvalent staphylococcal bacteriophage 812.
    Eyer L; Pantůcek R; Zdráhal Z; Konecná H; Kaspárek P; Růzicková V; Hernychová L; Preisler J; Doskar J
    Proteomics; 2007 Jan; 7(1):64-72. PubMed ID: 17154272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs against superbugs: private lessons from bacteriophages.
    Brown ED
    Trends Biotechnol; 2004 Sep; 22(9):434-6. PubMed ID: 15331220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinventing phage therapy: are the parts greater than the sum?
    Fischetti VA; Nelson D; Schuch R
    Nat Biotechnol; 2006 Dec; 24(12):1508-11. PubMed ID: 17160051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.
    Vaks L; Benhar I
    Methods Mol Biol; 2011; 726():187-206. PubMed ID: 21424451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage therapy: a reappraisal of bacteriophages as antibiotics.
    Inal JM
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):237-44. PubMed ID: 12956433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting bacterial infections-future treatment options.
    Fernebro J
    Drug Resist Updat; 2011 Apr; 14(2):125-39. PubMed ID: 21367651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inactivation of staphylococcal and colon bacillus bacteriophage by dendrochin].
    Bilaĭ VI; Kharchenko SN
    Mikrobiol Zh; 1970; 32(5):606-10. PubMed ID: 4252939
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectives.
    Borysowski J; Lobocka M; Międzybrodzki R; Weber-Dabrowska B; Górski A
    BioDrugs; 2011 Dec; 25(6):347-55. PubMed ID: 22050337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M; Adamia R
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotypes, antibiogram and phage types of Staphylococcus epidermis of human origin.
    Natesan V; Mohapatra LN; Bhujwala RA
    Indian J Pathol Microbiol; 1980 Jul; 23(3):199-204. PubMed ID: 6450732
    [No Abstract]   [Full Text] [Related]  

  • 14. Delivery systems to increase the selectivity of antibiotics in phagocytic cells.
    Briones E; Colino CI; Lanao JM
    J Control Release; 2008 Feb; 125(3):210-27. PubMed ID: 18077047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilms--a neglected antibacterial target?
    Toney JH
    Curr Opin Investig Drugs; 2007 Aug; 8(8):598-9. PubMed ID: 17668361
    [No Abstract]   [Full Text] [Related]  

  • 16. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.
    van Wamel WJ; Rooijakkers SH; Ruyken M; van Kessel KP; van Strijp JA
    J Bacteriol; 2006 Feb; 188(4):1310-5. PubMed ID: 16452413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations].
    Krylov VN
    Genetika; 2001 Jul; 37(7):869-87. PubMed ID: 11558226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophages: an appraisal of their role in the treatment of bacterial infections.
    Hanlon GW
    Int J Antimicrob Agents; 2007 Aug; 30(2):118-28. PubMed ID: 17566713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage therapy: exploiting smaller fleas.
    Deresinski S
    Clin Infect Dis; 2009 Apr; 48(8):1096-101. PubMed ID: 19275495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the interrelation of the resistance of pathogenic staphylococci to antibiotics, their virulence and phage type].
    CHISTOVICH GN
    Antibiotiki; 1963 Jan; 8():64-7. PubMed ID: 14020901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.